Imipenem and cephem resistant Pseudomonas aeruginosa carrying plasmids coding for class B beta-lactamase

The Journal of Antimicrobial Chemotherapy
S MinamiS Mitsuhashi

Abstract

From October 1988 to January 1992, nine isolates of Pseudomonas aeruginosa carrying transferable plasmids encoding imipenem-hydrolyzing beta-lactamase (pI = c. 9.5) were recovered from nine different patients in a neurosurgical ward of a hospital in Japan. The beta-lactamase activities of the sonicated extracts from the transconjugants were inhibited by EDTA and this was partially reversible by the addition of zinc cation. The substrate specificity and pI of the beta-lactamase were similar to those of the metallo beta-lactamases from P. aeruginosa and Serratia marcescens TN9106. All strains were resistant to imipenem, carbenicillin and antipseudomonal cephems including ceftazidime, cefsulodin, cefpirome, while four and five strains were susceptible to piperacillin and aztreonam, respectively. Both low level imipenem resistance and high level cephem resistance were co-transferred with the production of metallo beta-lactamase, while resistance to piperacillin, aztreonam, and high level imipenem-resistance were not selected. Production of chromosomal cephalosporinase in piperacillin resistant strains was derepressed, and production of outer membrane protein of D2 was diminished in highly imipenem resistant strains. Six strains wer...Continue Reading

Citations

Nov 22, 1997·Diagnostic Microbiology and Infectious Disease·E J Giamarellos-BourboulisH Giamarellou
Oct 26, 2000·Current Opinion in Microbiology·D M Livermore, N Woodford
Jul 17, 1999·European Journal of Biochemistry·J Walther-RasmussenN Høiby
Jul 18, 2000·Antimicrobial Agents and Chemotherapy·S IyobeK O'Hara
Nov 4, 2000·Expert Opinion on Investigational Drugs·D J PayneJ H Bateson
Jun 13, 2013·Environmental Microbiology Reports·Takahiro SegawaKazunari Ushida
Feb 19, 2020·Microbiology and Immunology·Yoshichika Arakawa
Jan 30, 1999·Antimicrobial Agents and Chemotherapy·T KöhlerJ C Pechere
Mar 9, 2021·Frontiers in Microbiology·Eun-Jeong Yoon, Seok Hoon Jeong
Feb 1, 1997·Antimicrobial Agents and Chemotherapy·B A Rasmussen, K Bush
Jan 1, 1996·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Isamu SaikawaYasuo Watanabe
Feb 3, 2000·Journal of Clinical Microbiology·A TakahashiS Iyobe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.